Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simultaneous vaccination for hepatitis A and B.

B Flehmig1, U Heinricy, M Pfisterer

  • 1Department of Medical Virology and Epidemiology of Virus Diseases, University of Tübingen, West Germany.

The Journal of Infectious Diseases
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[More pain assessment in individuals with advanced dementia! : Appropriate treatment is not possible without targeted observation].

Schmerz (Berlin, Germany)·2019
Same author

Prognostic impact of systemic inflammatory diseases in elderly patients with congestive heart failure.

QJM : monthly journal of the Association of Physicians·2013
Same author

Improved two-year outcomes after drug-eluting versus bare-metal stent implantation in women and men with large coronary arteries: importance of vessel size.

International journal of cardiology·2013
Same author

[Palliative care in geriatrics].

Deutsche medizinische Wochenschrift (1946)·2013
Same author

[Consensus for the identification of geriatric patients in the emergency care setting in Germany].

Zeitschrift fur Gerontologie und Geriatrie·2012
Same author

[Palliative care for patients with dementia].

Zeitschrift fur Gerontologie und Geriatrie·2012
Same journal

Pharyngeal gonorrhea in Ugandan men with urogenital gonorrhea: differences in antimicrobial resistance and strain types between anatomical sites.

The Journal of infectious diseases·2026
Same journal

Proactive Surveillance of Public Swimming Pools to Prevent Delayed Detection of Cryptosporidiosis Outbreaks.

The Journal of infectious diseases·2026
Same journal

Diverse genetic lineages spreading across healthcare and community boundaries underlie extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) colonization burden in Botswana.

The Journal of infectious diseases·2026
Same journal

Retraction of: Tracking Plasmodium knowlesi Through Fecal DNA for Monitoring Zoonotic Transmission in Wild Macaques Across Southeast and South Asia.

The Journal of infectious diseases·2026
Same journal

Can malaria induce loss of vaccine immunity.

The Journal of infectious diseases·2026
Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026
See all related articles

This study shows a combined hepatitis A and B vaccine effectively generates high antibody titers against both viruses. Even after 48 weeks, protective antibody levels against hepatitis A virus (HAV) and hepatitis B virus (HBV) remained elevated.

Area of Science:

  • Immunology
  • Vaccinology
  • Hepatology

Background:

  • Hepatitis A virus (HAV) and hepatitis B virus (HBV) are significant global health concerns.
  • Effective vaccination strategies are crucial for preventing HAV and HBV infections.

Purpose of the Study:

  • To evaluate the immunogenicity and efficacy of a combined hepatitis A and B vaccine.
  • To assess antibody responses against HAV and HBV following vaccination.

Main Methods:

  • 15 seronegative volunteers received a combined HAV/HBV vaccine at three 1-month intervals.
  • The vaccine comprised killed HAV and yeast-derived hepatitis B surface antigen (HBsAg).
  • Antibody titers against HAV and HBV were measured post-vaccination.

Main Results:

Related Experiment Videos

  • A single dose induced neutralizing antibodies for HAV with titers comparable to gamma globulin.
  • Three doses resulted in significantly higher anti-HAV antibody titers compared to HAV vaccine alone.
  • 14 out of 15 volunteers seroconverted against HBV after three doses.
  • High antibody titers against both HAV and HBV were sustained at 48 weeks post-vaccination.

Conclusions:

  • The combined HAV/HBV vaccine is immunogenic and elicits robust antibody responses.
  • Simultaneous vaccination against HBV enhances the immune response to HAV.
  • Sustained high antibody levels suggest long-term protection against HAV and HBV.